TOG Review (RCOG Journal)
MRCOG Part 2
Postpartum Problems (Maternal)
The use of psychotropic medication in the perinatal period
Key Statistics
- 10–20% — Women with a perinatal mental health problem
- 47% — Clinicians advising stopping antidepressants once pregnant
- 10% / 30–40% — Valproate: Major malformation / neurodevelopmental disorder risk
Don't-miss facts
-
Sodium valproate is contraindicated in anyone of childbearing potential (10% malformation, 30–40% neurodevelopmental disorder risk) except under the Pregnancy Prevention Programme
-
Lithium: level 12h post-dose; toxic >1.2 mmol/L, potentially fatal >2.0 mmol/L; breastfeeding not currently recommended; never use cabergoline to suppress lactation
-
Clozapine – breastfeeding contraindicated; monitor in-utero exposed infants for agranulocytosis for 6 months
-
PNAS (up to 30% antidepressant-exposed) is not dose-dependent – do NOT reduce dose near term to try to prevent it
-
Olanzapine/quetiapine specifically raise GDM and macrosomia risk – offer 28-week OGTT
-
Carbamazepine/enzyme inducers reduce hormonal contraceptive efficacy – offer alternative postnatal contraception; give newborn IM vitamin K
-
Benzodiazepine severe CNS depression is reversible with flumazenil; discourage co-sleeping on sedating medication (SIDS risk)
-
47% of clinicians still advise stopping antidepressants on confirmation of pregnancy – guidelines advise against routine discontinuation
Safety snapshot
Generally compatible: SSRIs (sertraline pref. in breastfeeding), SNRIs, NaSSAs, TCAs, FGAs/SGAs (not clozapine), benzodiazepines (lorazepam pref.), Z-hypnotics, antihistamines
Contraindicated/high caution: sodium valproate (childbearing potential); lithium + breastfeeding; clozapine + breastfeeding; cabergoline for lactation suppression in lithium/psychosis risk
Abbreviation Key
- SSRI — selective serotonin reuptake inhibitor
- GDM — gestational diabetes mellitus
- SNRI — serotonin and noradrenaline reuptake inhibitor
- OGTT — oral glucose tolerance test
- NaSSA — noradrenaline and specific serotonergic antidepressant
- HBGM — home blood glucose monitoring
- TCA — tricyclic antidepressant
- FASP — fetal anomaly screening programme
- FGA/SGA — first-/second-generation antipsychotic; SGA also =
- LBW — low birth weight small for gestational age (context dependent)
- FBC — full blood count
- PNAS — poor neonatal adaptation syndrome
- CS — caesarean section
- PPHN — persistent pulmonary hypertension of the newborn
- UKTIS — UK Teratology Information Service
- EPSE — extrapyramidal side effect
- BUMPS — Best Use of Medicines in Pregnancy
- NMS — neuroleptic malignant syndrome
- LactMed — Drugs and Lactation Database
Source: Petrosellini C et al. The use of psychotropic medication in the perinatal period. The Obstetrician & Gynaecologist 2024;26:127–138. doi:10.1111/tog.12936
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).